130 related articles for article (PubMed ID: 24009834)
1. Kalopanaxsaponin B Ameliorates TNBS-Induced Colitis in Mice.
Jeong JJ; Jang SE; Joh EH; Han MJ; Kim DH
Biomol Ther (Seoul); 2012 Sep; 20(5):457-62. PubMed ID: 24009834
[TBL] [Abstract][Full Text] [Related]
2. Kalopanaxsaponin A ameliorates experimental colitis in mice by inhibiting IRAK-1 activation in the NF-κB and MAPK pathways.
Joh EH; Kim DH
Br J Pharmacol; 2011 Apr; 162(8):1731-42. PubMed ID: 21198552
[TBL] [Abstract][Full Text] [Related]
3. Echinocystic acid, a metabolite of lancemaside A, inhibits TNBS-induced colitis in mice.
Hyam SR; Jang SE; Jeong JJ; Joh EH; Han MJ; Kim DH
Int Immunopharmacol; 2013 Feb; 15(2):433-41. PubMed ID: 23352442
[TBL] [Abstract][Full Text] [Related]
4. Kalopanaxsaponin B inhibits LPS-induced inflammation by inhibiting IRAK1 Kinase.
Joh EH; Jeong JJ; Kim DH
Cell Immunol; 2012 Sep; 279(1):103-8. PubMed ID: 23117333
[TBL] [Abstract][Full Text] [Related]
5. Mangiferin ameliorates colitis by inhibiting IRAK1 phosphorylation in NF-κB and MAPK pathways.
Jeong JJ; Jang SE; Hyam SR; Han MJ; Kim DH
Eur J Pharmacol; 2014 Oct; 740():652-61. PubMed ID: 24972244
[TBL] [Abstract][Full Text] [Related]
6. Berberine ameliorates TNBS-induced colitis by inhibiting lipid peroxidation, enterobacterial growth and NF-κB activation.
Lee IA; Hyun YJ; Kim DH
Eur J Pharmacol; 2010 Dec; 648(1-3):162-70. PubMed ID: 20828550
[TBL] [Abstract][Full Text] [Related]
7. Lancemaside A ameliorates colitis by inhibiting NF-kappaB activation in TNBS-induced colitis mice.
Joh EH; Lee IA; Han SJ; Chae S; Kim DH
Int J Colorectal Dis; 2010 May; 25(5):545-51. PubMed ID: 19956958
[TBL] [Abstract][Full Text] [Related]
8. Lactobacillus suntoryeus inhibits pro-inflammatory cytokine expression and TLR-4-linked NF-kappaB activation in experimental colitis.
Lee JH; Lee B; Lee HS; Bae EA; Lee H; Ahn YT; Lim KS; Huh CS; Kim DH
Int J Colorectal Dis; 2009 Feb; 24(2):231-7. PubMed ID: 19050899
[TBL] [Abstract][Full Text] [Related]
9. Lactobacillus brevis G-101 ameliorates colitis in mice by inhibiting NF-κB, MAPK and AKT pathways and by polarizing M1 macrophages to M2-like macrophages.
Jang SE; Hyam SR; Han MJ; Kim SY; Lee BG; Kim DH
J Appl Microbiol; 2013 Sep; 115(3):888-96. PubMed ID: 23742179
[TBL] [Abstract][Full Text] [Related]
10. Arctigenin ameliorates inflammation in vitro and in vivo by inhibiting the PI3K/AKT pathway and polarizing M1 macrophages to M2-like macrophages.
Hyam SR; Lee IA; Gu W; Kim KA; Jeong JJ; Jang SE; Han MJ; Kim DH
Eur J Pharmacol; 2013 May; 708(1-3):21-9. PubMed ID: 23375938
[TBL] [Abstract][Full Text] [Related]
11. Ginsenoside Re ameliorates inflammation by inhibiting the binding of lipopolysaccharide to TLR4 on macrophages.
Lee IA; Hyam SR; Jang SE; Han MJ; Kim DH
J Agric Food Chem; 2012 Sep; 60(38):9595-602. PubMed ID: 22849695
[TBL] [Abstract][Full Text] [Related]
12. Ursolic acid isolated from the seed of Cornus officinalis ameliorates colitis in mice by inhibiting the binding of lipopolysaccharide to Toll-like receptor 4 on macrophages.
Jang SE; Jeong JJ; Hyam SR; Han MJ; Kim DH
J Agric Food Chem; 2014 Oct; 62(40):9711-21. PubMed ID: 25213465
[TBL] [Abstract][Full Text] [Related]
13. Anticolitic Effect of the Rhizome Mixture of Anemarrhena asphodeloides and Coptidis chinensis (AC-mix) in Mice.
Jang SE; Jeong JJ; Hyam SR; Han MJ; Kim DH
Biomol Ther (Seoul); 2013 Sep; 21(5):398-404. PubMed ID: 24244828
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effect of β-sitosterol on TNBS-induced colitis in mice.
Lee IA; Kim EJ; Kim DH
Planta Med; 2012 Jun; 78(9):896-8. PubMed ID: 22538477
[TBL] [Abstract][Full Text] [Related]
15. Neomangiferin modulates the Th17/Treg balance and ameliorates colitis in mice.
Lim SM; Kang GD; Jeong JJ; Choi HS; Kim DH
Phytomedicine; 2016 Feb; 23(2):131-40. PubMed ID: 26926174
[TBL] [Abstract][Full Text] [Related]
16. Kalopanaxsaponin A Exerts Anti-Inflammatory Effects in Lipopolysaccharide-Stimulated Microglia via Inhibition of JNK and NF-κB/AP-1 Pathways.
Jeong YH; Hyun JW; Kim Van Le T; Kim DH; Kim HS
Biomol Ther (Seoul); 2013 Sep; 21(5):332-7. PubMed ID: 24244819
[TBL] [Abstract][Full Text] [Related]
17. Timosaponin AIII and its metabolite sarsasapogenin ameliorate colitis in mice by inhibiting NF-κB and MAPK activation and restoring Th17/Treg cell balance.
Lim SM; Jeong JJ; Kang GD; Kim KA; Choi HS; Kim DH
Int Immunopharmacol; 2015 Apr; 25(2):493-503. PubMed ID: 25698557
[TBL] [Abstract][Full Text] [Related]
18. Lactobacillus sakei K17, an inducer of IL-10 expression in antigen-presenting cells, attenuates TNBS-induced colitis in mice.
Eun SH; Lim SM; Jang SE; Han MJ; Kim DH
Immunopharmacol Immunotoxicol; 2016 Dec; 38(6):447-454. PubMed ID: 27600362
[TBL] [Abstract][Full Text] [Related]
19. Amelioration of colitis in mice by Leuconostoc lactis EJ-1 by M1 to M2 macrophage polarization.
Jang SE; Min SW
Microbiol Immunol; 2020 Feb; 64(2):133-142. PubMed ID: 31625616
[TBL] [Abstract][Full Text] [Related]
20. Ginsenoside Rb1 and its metabolite compound K inhibit IRAK-1 activation--the key step of inflammation.
Joh EH; Lee IA; Jung IH; Kim DH
Biochem Pharmacol; 2011 Aug; 82(3):278-86. PubMed ID: 21600888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
